The site-sponsor relationship is a multi-faceted one. The need for communication and understanding between the two is prevalent now more than ever.
When conducting an investigator-initiated trial, oftentimes, an investigational new drug or investigational device exemption application is necessary. Learn more about IND and IDE reporting.
Guide patient enrollment in the right direction and make better decisions on every study.
Effective budget negotiation is consistently a hot topic for clinical research sites. Here are a few tips to make sure your site gets the most from your negotiations.
Coordinating centers often struggle with the administrative burden of managing regulatory documents across multiple participating sites. We collaborated with our customers to address this challenge through the Forte eRegulatory Management System.
The 11th annual AACI-CRI conference is quickly approaching, drawing academic clinical research leaders from across the country. We preview some of the key focus areas of the 2019 conference.
The relationship between sites and sponsors may not always be a smooth one. A strong relationship between a research site and a sponsor can improve activation timelines, ensure smooth trial conduct and help build relationships for future studies.
Forte and ACRP partnered to conduct a survey analyzing the factors that contribute to technology competency and how sites, technology providers and clinical research professionals can work to improve these competencies across the industry.
At last week’s 2019 Spring Onsemble Conference, we shared progress we’ve made for customers with Forte products and services, as well as the Onsemble Community’s progress toward connecting key industry stakeholders.